CBT Enriched With Emotion Regulation Training for Multiple Somatoform Symptoms (ENCERT) - A 3-year Follow-up
ENCERT-3YFU
Enriching Cognitive-Behavioral Therapy With Emotion Regulation Training in Patients With Chronic Multiple Somatoform Symptoms (ENCERT): A 3-Year Follow-up of a Randomized Controlled Trial
2 other identifiers
interventional
255
1 country
1
Brief Summary
The purpose of this study is to evaluate whether 3 years after the end of therapy cognitive-behavioral therapy complemented with strategies from emotion regulation training leads to better improvement in somatic symptoms and comorbid problems in patients with chronic multiple somatoform symptoms than cognitive behavioral therapy alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2017
CompletedFirst Submitted
Initial submission to the registry
June 8, 2019
CompletedFirst Posted
Study publicly available on registry
June 11, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2019
CompletedJuly 14, 2025
July 1, 2025
2.5 years
June 8, 2019
July 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in somatic symptom severity (Screening of Somatoform Disorders, SOMS-7T) from pre-assessment to 3-year follow-up
Assessment of somatic symptom severity during the last 7 days (self-rating)
From pre-assessment (admission) to follow-up (42 months after admission)
Secondary Outcomes (7)
Change in depressive symptoms (Beck Depression Inventory-II, BDI-II) from pre-assessment to 3-year follow-up
From pre-assessment (admission) to follow-up (42 months after admission)
Change in emotion regulation skills (Emotion Regulation Skills Questionnaire, ERSQ) from pre-assessment to 3-year follow-up
From pre-assessment (admission) to follow-up (42 months after admission)
Change in symptom-focused coping strategies (Pain Coping Questionnaire) from pre-assessment to 3-year follow-up
From pre-assessment (admission) to follow-up (42 months after admission)
Change in general psychopathological symptoms (Symptom Checklist-90, SCL-90) from pre-assessment to 3-year follow-up
From pre-assessment (admission) to follow-up (42 months after admission)
Change in symptom-caused disability (Pain Disability Index, PDI) from pre-assessment to 3-year follow-up
From pre-assessment (admission) to follow-up (42 months after admission)
- +2 more secondary outcomes
Study Arms (2)
CBT complemented with emotion regulation training
EXPERIMENTALENCERT contains 1) psychoeducation (session1), 2) relaxation techniques for coping with stress (sessions 2-4), 3) non-judgmental awareness of body perceptions, (sessions 5-7), 4) modifying illness behavior and accepting unpleasant body perceptions (sessions 8-13), 5) attention defocusing on positive perceptions plus emotional self-support (sessions 14- 15), 6) analyzing interpretation processes to understand situational cues (sessions 16-17), and 7) change of behavior and interpretations (sessions 18-20). The innovative elements of ENCERT are: improving the awareness for the association of somatic symptoms with emotions, learning nonjudgmental awareness and acceptance of unpleasant body perceptions, achieving high-frequent skill exercising with the emotion regulation audio training.
Cognitive behavior therapy (CBT)
ACTIVE COMPARATORThis arm is based on conventional cognitive-behavioral therapy that can be considered the current "treatment of choice", being the only intervention with an evidence grade 1a (Kroenke, 2007). As such, it presents the reference of efficacy and safety for new regimen. The strictly manualized program includes the following components focusing on the special needs of chronic somatoform patients: psychoeducation providing a framework for psychotherapy, attention defocusing, reduction of over-interpretation of symptoms, increase of physical activity, stress reduction.
Interventions
Cognitive-behavioral therapy + emotion regulation training for patients with multiple somatoform symptoms: 20 weekly sessions individual therapy (à 50 minutes)
Cognitive-behavioral therapy for patients with multiple somatoform symptoms: 20 weekly sessions individual therapy (à 50 minutes)
Eligibility Criteria
You may qualify if:
- Multiple distressing somatic symptoms (≥ 3 symptoms) not fully explained by a medical condition
- Pain Disability Index (mPDI) total score ≥ 4
- Patient Health Questionnaire-15 (PHQ-15) ≥ 5
- Requested psychological criteria for SSD (at least 1 of 3):
- Disproportionate and persistent thoughts about the seriousness of one's symptoms
- Persistently high level of anxiety about health or symptoms
- Excessive time and energy devoted to these symptoms or health concerns
- Symptom duration ≥ 6 months
- Age: 18-69 years
- Comorbidity (depression, other mental disorders) allowed, as long as somatic symptoms are considered to be the major problem by therapist and patient
- Thorough medical check for medical disease that might fully explain the somatic symptoms
- Documented medical evaluation
You may not qualify if:
- Severe alcohol/drug addiction
- Acquired brain injuries
- Psychoses (history of schizophrenia spectrum disorders; bipolar disorders)
- Primary disorder requesting other treatments (e.g., suicidality)
- Biomedical etiology of major symptoms (also if detected during treatment course
- Ongoing psychotherapy
- Continuous or intermittent, high-dosage (on average more than once per 2 weeks) benzodiazepine treatment
- Continuous antipsychotic treatment
- Continuous opioid treatment
- For patients on medication with antidepressants: treatment regime changes during the time between 4 weeks prior to treatment until follow-up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Psychology, Philipps University Marburg
Marburg, Hesse, 35032, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maria Kleinstäuber, PhD
Philipps University Marburg
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 8, 2019
First Posted
June 11, 2019
Study Start
April 1, 2017
Primary Completion
September 30, 2019
Study Completion
September 30, 2019
Last Updated
July 14, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Immediately following publication; no end date
- Access Criteria
- Proposals should be directed to the corresponding author (MK; maria.kleinstaeuber@staff.uni-marburg.de). To gain access, data requestors will need to sign a data access agreement. Data are not publicly available because informed consent provided by participants of this study is committed to a defined purpose.
Data sharing statement Will individual participant data be available (including data dictionaries)? Yes What data in particular will be shared? Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices). What other documents will be available? Study protocol With whom? Researchers who provide a methodologically sound proposal for re-analyses For what types of analyses? For re-analyses if their aim is covered by the purpose described and agreed on in the patient information sheet and informed consent.